Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
暂无分享,去创建一个
H. Eguchi | M. Monden | K. Dono | A. Miyamoto | H. Nagano | K. Umeshita | K. Wakasa | H. Yamamoto | N. Matsuura | Hirofumi Yamamoto | M. Sakon | S. Nakamori | Y. Ito | J. Okami | M. Kondo | H. Eguchi | J. Shimizu | Yasuhiro Ito
[1] M. Monden,et al. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] J. Masferrer,et al. Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites. , 1999, Gastroenterology.
[3] J. Tang,et al. Liver resection for hepatocellular carcinoma in octogenarians. , 1999, Surgery.
[4] T. Fahey,et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. , 1999, Cancer research.
[5] T. Kawaguchi,et al. Expression of cyclooxygenase‐2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation , 1999, Hepatology.
[6] I. Schieren,et al. Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells , 1999, Oncogene.
[7] A. Castonguay,et al. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. , 1998, Cancer research.
[8] J. Morrow,et al. Meloxicam inhibits the growth of colorectal cancer cells. , 1998, Carcinogenesis.
[9] A. Ristimäki,et al. Expression of cyclooxygenase-2 in human lung carcinoma. , 1998, Cancer research.
[10] M. Taketo. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). , 1998, Journal of the National Cancer Institute.
[11] M. Hori,et al. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.
[12] M. Taketo,et al. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. , 1998, Cancer research.
[13] T. Sugimura,et al. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. , 1998, Carcinogenesis.
[14] A. Levine,et al. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. , 1998, Cancer research.
[15] Y. Yatabe,et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.
[16] I. Singer,et al. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. , 1998, Gastroenterology.
[17] R. DuBois,et al. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.
[18] S. Meltzer,et al. Advances in Brief Increased Expression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Barrett ' s Esophagus and Associated Adenocarcinomas 1 , 2006 .
[19] T. Nabika,et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver , 1998, Hepatology.
[20] R. DuBois,et al. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.
[21] D. Scollard,et al. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. , 1998, Journal of the National Cancer Institute.
[22] K. Seibert,et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. , 1998, Cancer research.
[23] T. Sugimura,et al. Suppression of Intestinal Polyp Development by Nimesulide, a Selective Cyclooxygenase‐2 Inhibitor, in Min Mice , 1997, Japanese journal of cancer research : Gann.
[24] J. Vane. Suppression of intestinal polyposis by inhibition of COX-2 in Apc knockout mice. , 1997, Japanese journal of cancer research : Gann.
[25] E. Okajima,et al. Inhibition by piroxicam of oxidative DNA damage, liver cirrhosis and development of enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats. , 1997, Carcinogenesis.
[26] L. Schwartz,et al. Automated Double Labeling of Proliferation and Apoptosis in Glutathione S-transferase-positive Hepatocytes in Rats , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[27] N. Yoshimi,et al. Apoptosis Induced by NS‐398, a Selective Cyclooxygenase‐2 Inhibitor, in Human Colorectal Cancer Cell Lines , 1997, Japanese journal of cancer research : Gann.
[28] J. Morrow,et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. , 1997, The Journal of clinical investigation.
[29] A. Ristimäki,et al. Expression of cyclooxygenase-2 in human gastric carcinoma. , 1997, Cancer research.
[30] A. Kakita,et al. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus‐associated cirrhosis and HCC , 1997, Cancer.
[31] M. Runge,et al. Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[32] W. Jiménez,et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. , 1996, Hepatology.
[33] Bruno C. Hancock,et al. Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.
[34] T. Kin,et al. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. , 1996, Annals of surgery.
[35] K. Seibert,et al. Advances in Brief Evaluation of Cyclooxygenase-2 Inhibitor for Potential Chemopreventive Properties in Colon Carcinogenesis ' , 2006 .
[36] D. Huhn,et al. Quantification of Bcr-Abl transcripts in chronic myelogenous leukemia (CML) using standardized, internally controlled, competitive differential PCR (CD-PCR). , 1996, Nucleic acids research.
[37] T. Kin,et al. Influence of Associated Viral Hepatitis Status on Recurrence of Hepatocellular Carcinoma after Hepatectomy , 1996, World Journal of Surgery.
[38] E. Sigal,et al. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. , 1996, British journal of rheumatology.
[39] J. Maclouf,et al. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. , 1996, Experimental cell research.
[40] M. Kondo,et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.
[41] N. Okamoto,et al. Role of Increased DNA Synthesis Activity of Hepatocytes in Multicentric Hepatocarcinogenesis in Residual Liver of Hepatectomized Cirrhotic Patients with Hepatocellular Carcinoma , 1994, Japanese journal of cancer research : Gann.
[42] R. Coffey,et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.
[43] R. Everson,et al. Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.
[44] J. Morrow,et al. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. , 1994, The Journal of clinical investigation.
[45] A. Ford-hutchinson,et al. Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues , 1993, FEBS letters.
[46] K. Chayama,et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis , 1993, Hepatology.
[47] R. Hardman,et al. Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. , 1993, Archives of biochemistry and biophysics.
[48] David A Jones,et al. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. , 1993, The Journal of biological chemistry.
[49] P. Ternes,et al. An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. , 1993, BioTechniques.
[50] K. Tanikawa,et al. The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound‐guided fine‐needle biopsy with those of autopsy , 1992, Cancer.
[51] T. Hla,et al. Human cyclooxygenase-2 cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[52] K. Okuda,et al. Hepatocellular carcinoma: Recent progress , 1992, Hepatology.
[53] P. Vielh,et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.
[54] M. Makuuchi,et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma , 1990, The Lancet.
[55] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[56] K. Schrör,et al. Cyclooxygenase-2 expression in human esophageal carcinoma. , 1999, Cancer research.
[57] H. Kawasaki,et al. Cyclooxygenase-2 expression in hepatocellular carcinoma. , 1999, Hepato-gastroenterology.
[58] 澤岡 均. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice , 1999 .
[59] G. Cattoretti,et al. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. , 1998, Cancer research.
[60] M. Taketo. Cyclooxygenase-2 inhibitors in tumorigenesis (part I). , 1998, Journal of the National Cancer Institute.
[61] B. Gellersen,et al. Cloning of guinea pig cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase complementary deoxyribonucleic acids: steroid-modulated gene expression correlates to prostaglandin F2 alpha secretion in cultured endometrial cells. , 1997, Endocrinology.
[62] J. Travers,et al. Aspirin use and reduced risk of fatal colon cancer. , 1992, The New England journal of medicine.
[63] P. Romeo,et al. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[64] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.